JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minami, K.
Right arrow Articles by Harris, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minami, K.
Right arrow Articles by Harris, R. A.

Vol. 281, Issue 3, 1136-1143, 1997

Inhibition of 5-Hydroxytryptamine Type 2A Receptor-Induced Currents by n-Alcohols and Anesthetics1

Kouichiro Minami, Makiko Minami and R. Adron Harris

Department of Pharmacology, University of Colorado Health Sciences Center and Veterans Affairs Medical Center, Denver, Colorado


    Abstract
Top
Abstract
Introduction
Procedures
Results
Discussion
References

5-Hydroxytryptamine type 2A receptors (5-HT2A) are G protein-coupled receptors that increase intracellular Ca2+ concentrations via activation of phospholipase C-beta and elevation of myo-inositol-1,4,5-triphosphate levels. In the central nervous system, these receptors are involved in regulating sleep and alertness. We now report that ethanol inhibited (IC50 = 41 mM) 5-HT2A receptor-induced Ca2+-dependent Cl- currents in Xenopus laevis oocytes. Pharmacologically relevant concentrations of other n-alcohols (propanol to octanol) also inhibited 5-HT responses; however, longer-chain alcohols (decanol, undecanol and dodecanol) had little or no effect. The protein kinase C inhibitor GF109203X and the nonspecific protein kinase inhibitor staurosporine abolished the inhibitory effects of ethanol and octanol on 5-HT2A receptors. GF109203X enhanced 5-HT2A receptor function when administered alone. In addition, the volatile anesthetics halothane and 1-chloro-1,2,2-trifluorocyclobutane decreased 5-HT2A responses in a concentration-dependent manner. The inhibitory effects of the volatile anesthetics were also attenuated in oocytes treated with GF109203X. The intravenous anesthetics propofol, ketamine, pentobarbital and etomidate did not affect 5-HT2A receptor function. The modulation of 5-HT2A receptor-dependent current was also investigated using two novel halogenated compounds that do not produce anesthesia. The nonanesthetic compound 2,3-chloro-octafluorobutane had no effects on 5-HT-induced currents; however, the nonanesthetic compound 1,2-dichlorohexafluorocyclobutane had an inhibitory effect at lower concentrations than the predicted anesthetic concentration. Thus, 5-HT2A receptors are inhibited by alcohols and volatile anesthetics, and these actions are dependent on protein kinase C.


    Introduction
Top
Abstract
Introduction
Procedures
Results
Discussion
References

5-HT (serotonin) is an important biogenic amine that fulfills the role of both a neurotransmitter and neuromodulator (Gyermek, 1996). Seven different families of serotonin receptors have been identified, including the 5-HT2A receptors. 5-HT2 receptors in the central nervous system are important in regulating sleep and alertness (Huidobro-Toro and Harris, 1996; Sharpley et al., 1990). Recently, it has been reported that the 5-HT2A receptor is involved in alcohol tolerance and dependence (LeMarquand et al., 1994a, 1994b; Pandey and Pandey, 1996).

The effects of ethanol and anesthetics on voltage- and ligand-gated ion channels have been the focus of several studies (reviewed in Franks and Lieb, 1994; Harris et al., 1995). However, less is known about the effects of ethanol and anesthetics on metabotropic receptors, such as 5-HT2 receptors. Several investigators have recently studied the effects of ethanol and anesthetics on some G protein-coupled receptors (Durieux, 1995, 1996; Lin et al., 1993, Sanna et al., 1994). The volatile anesthetic enflurane inhibited the function of phoshatidylinositol-linked acetylcholine and serotonin receptors (Lin et al., 1993); ethanol inhibited the function of 5-HT2C and muscarinic m1 G protein-linked receptors (Sanna et al., 1994) and halothane inhibited the muscarinic m1 receptor expressed in Xenopus laevis oocytes (Durieux, 1995). The inhibitory actions of ethanol on 5-HT2C and m1 receptor was attributed to PKC-mediated receptor desensitization. It is interesting to note that the angiotensin II receptor, which uses the same intracellular signaling system as the m1 muscarinic receptor, was not affected by halothane (Durieux, 1995), and desensitization of this receptor is not modulated by PKC (Oppermann et al., 1996).

These studies raise a number of questions. First, only a few anesthetic agents have been tested on metabotropic receptors. To determine whether inhibition of these receptors might be related to anesthetic action in vivo, it is necessary to examine a wider range of compounds. In particular, there are structurally related compounds in which a small structural change converts an anesthetic into a nonanesthetic (Koblin et al., 1994). Also, the long-chain n-alcohols produce anesthesia but do not affect some of the ligand-gated ion channels that are sensitive to ethanol (Dildy-Mayfield et al., 1996a). Second, as noted above, the 5-HT2 family of receptors is important in brain function, and earlier studies (Lin et al., 1993; Sanna et al., 1994) of the effects of ethanol and anesthetics on these receptors used brain mRNA to express putative 5-HT2C receptors in X. laevis oocytes. However, interpretation of these results is complicated by other proteins, including other 5-HT2 receptors, that could be expressed from a mixture of mRNAs. Third, there is evidence that ethanol inhibition of 5-HT responses requires PKC (Sanna et al., 1994), but it is not known if this is also true for other anesthetics. In addition, those results were obtained by expression of brain mRNA, and it is important to confirm them by expression of cRNA for a single 5-HT receptor subtype. To answer these questions, we expressed 5-HT2A receptors in X. laevis oocytes and tested the effects of n-alcohols as well as volatile and injectable anesthetics on the function of these receptors.

The X. laevis oocyte expression system has been used to express a multiplicity of brain receptors from cDNAs or cRNAs with pharmacological properties that mimic those of native brain receptors (Harris. et al., 1995). The activation of 5-HT2A receptors by 5-HT results in an increase in intracellular free Ca2+ concentration. The rise in intracellular Ca2+ opens Ca2+-sensitive Cl- channels found endogenously in oocytes (Pritchett et al., 1988). This system has been well characterized and is well suited for studying the effects of ethanol and anesthetics on G protein-coupled receptors. We now report the effects of short- and long-chain alcohols, volatile and intravenous anesthetics and some novel nonanesthetics on the function of 5-HT2A receptors expressed in X. laevis oocytes. We also studied the effects of PKC inhibition on the modulation of 5-HT2A receptors by these agents.

    Experimental procedures
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials. Adult X. laevis laevis female frogs were purchased from Xenopus I (Ann Arbor, MI). 5-HT, the n-alcohols, DMSO, staurosporinee and ketamine were purchased from Sigma Chemical Co. (St. Louis, MO). Ethanol was purchased from Asper Alcohol and Chemical Co. (Shelbyville, KY). Propofol was obtained from Aldrich Chemical Co. (Milwaukee, WI). Halothane was bought from Halocarbons Laboratories (River Edge, NJ). Etomidate was obtained from Janssen Pharmaceutica (Beerse, Belgium). F3, F6 and F8 were obtained from PCR Inc. (Gainesville, FL). Spiperone and ritanserin were bought from Research Biochemicals Inc. (Natick, MA). N-(4-Bromobenzyl)-5-methoxytryptamine oxalate was obtained from Tocris Cookson (St. Louis, MO). Ultracomp Escherichia coli transformation kit was from InVitrogen (San Diego, CA). The Qiagen (Chatworth, CA) kit was used for purification of plasmid cDNA. 5-HT2A cRNA were prepared using mCAP mRNA capping kit (Stratagene, La Jolla, CA). GF109203X was bought from Calbiochem (La Jolla, CA). 5-HT2A cDNA was kindly provided by Dr. David Julius (University of California, San Francisco).

5-HT2A cRNA preparation. The cDNA for the 5-HT2A receptor was inserted into the pGEM vector. The receptor cDNA was linearized with HindIII, phenol chloroform-extracted and ethanol-precipitated with sodium acetate. cRNA was prepared using the Stratagene transcription kit by using T7 RNA polymerase. The cRNA was extracted using phenol-chloroform and precipitated in ethanol and sodium acetate.

Whole-cell voltage-clamp of injected oocytes. Isolation and microinjection of X. laevis oocytes were performed as described by Sanna et al. (1994) and Huidobro-Toro and Harris (1996). X. laevis oocytes were injected with 50 ng of cRNA for the 5-HT2A receptor. Oocytes were placed in a 100-µl recording chamber and perfused with MBS containing (mM): NaCl, 88; KCl, 1; NaHCO3, 2.4; HEPES, 10: MgSO4, 0.82; Ca(NO3)2, 0.33; CaCl2, 0.91, pH 7.5, at a rate of 1.8 ml/min at room temperature. Recording and clamping electrodes (1-5 MOmega ) were pulled from 1.2-mm o.d. capillary tubing and filled with 3 M KCl. A recording electrode was impaled into the animal pole; once the resting membrane potential stabilized, a clamping electrode was inserted, and the resting membrane potential was allowed to restabilize. The Warner oocyte clamp OC 725-B (Hampden, CT) was used for voltage-clamping each oocyte at -70 mV. For the poorly water-soluble alcohols (octanol-dodecanol), stocks were prepared in DMSO and diluted and sonicated in MBS to a final DMSO concentration not exceeding 0.05% (Dildy-Mayfield et al., 1996A). The alcohols, anesthetics and nonanesthetics were preapplied for 2 min to allow complete equilibration in the bath. Solutions of volatile agents were freshly prepared immediately before use. The alcohol, anesthetic and nonanesthetic concentrations in the figures represent bath concentrations. We used the previously published values to calculate the final concentration of volatile compounds in the recording chamber (Dildy-Mayfield et al., 1996a; Mihic et al. 1994). Although there was no loss of short-chain alcohols during oocyte perfusion, there was a 50% to 70% loss of n-alcohols ranging from octanol to decanol and a similar loss of volatile anesthetics (Dildy-Mayfield et al., 1996a; Lin et al., 1992; Mihic et al., 1994).

To study the effects of PKC on the effects of ethanol, octanol, anesthetics and nonanesthetics, oocytes were exposed to GF109203X (200 nM) (Toullec et al., 1991) or staurosporine (800 nM) in incubation media (MBS containing 10 mg of streptomycin and 10,000 units of penicillin G plus 50 mg of gentamycin/liter, 0.5 mM theophylline and 2 mM sodium pyruvate).

Statistical analysis. Results are expressed as percentages of control responses due to variability in oocyte expression. The control responses were measured before and after each drug application to take into account possible shifts in the control currents as recording proceeded. The n values refer to the number of oocytes studied. Each experiment was carried out with oocytes from at least two different frogs. Statistical analyses were performed with t test with Dunnett's correction for multiple comparisons or analysis of variance for repeated measures. Curve fitting and estimation of EC50 values for concentration-response curves were performed using GraphPAD Inplot Software (San Diego, CA).

    Results
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Ethanol inhibition of currents activated by 5-HT. 5-HT concentration-response curves were determined in X. laevis oocytes expressing 5-HT2A receptors. Nonlinear regression analysis of these curves yielded an EC50 value for 5-HT of 0.27 ± 0.04 µM and a Hill coefficient of 0.76 ± 0.15 (fig. 1A). Maximal currents were observed at 10 µM. The 5-HT2A receptor antagonists spiperone (100 nM) (Leysen et al., 1978), ritanserin (100 nM) (Leysen et al., 1985) and N-(4-bromobenzyl)-5-methoxytryptamine oxalate (100 nM) (Glennon et al., 1994) reduced the current induced by 10 nM 5-HT to 0%, 28 ± 5% and 25 ± 8% of control, respectively. Ethanol (25-200 mM) inhibited currents elicited by 0.01 and 0.1 µM 5-HT (fig. 1B). The concentration of ethanol producing half-maximal inhibition of 5-HT-induced currents was 41 ± 5 mM when a 10 nM concentration of 5-HT was used. The inhibition by 200 mM ethanol was 44 ± 2%, 40 ± 5%, 37 ± 3% and 36 ± 5% when 10 nM, 100 nM, 1 µM and 10 µM 5-HT were used (fig. 1C).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   A, Concentration-response curve for 5-HT (1 nM to 10 µM)-activated Ca2+-dependent Cl- current in X. laevis oocyte expressing 5-HT2A receptor. Oocytes were voltage-clamped at -70 mV; 5-HT was applied for 20 sec, and peak current was measured. Ordinate values represent the percentage of maximal current obtained with 10 µM 5-HT. Values are mean ± S.E.M. from 10 oocytes; see text for statistics. B, Ethanol (25-200 mM) inhibited in a concentration-dependent manner currents elicited by 10 or 100 nM 5-HT in X. laevis oocytes expressing 5-HT2A receptors. Ethanol was perfused for 2 min before being coapplied with 10 or 100 nM 5-HT. Data are mean ± S.E.M. of 8 oocytes. C, Ethanol inhibition of 5-HT action is observed with maximal and submaximal concentrations of 5-HT. Increasing concentrations of 5-HT (10 nM to 10 µM) were applied in the presence of 200 mM ethanol. Ethanol was perfused for 2 min before being coapplied with 5-HT (10 nM to 10 µM). Data are mean ± S.E.M. of 6 oocytes.

n-Alcohol inhibition of currents activated by 5-HT. n-Alcohols of increasing chain length were tested next. As shown in figure 2A, the long-chain alcohols decanol, undecanol and dodecanol did not significantly inhibit the current produced by 10 nM 5-HT. Higher doses were not used due to solubility problems. The shorter-chain alcohols inhibited the currents produced by 10 nM 5-HT (fig. 2A). The ED50 values in tadpoles for loss of righting reflex at room temperature are 190, 10.8, 0.57, 0.057, 0.037, 0.0126, 0.0081 and 0.0047 mM for ethanol, propanol, butanol, hexanol, octanol, decanol, undecanol and dodecanol, respectively (Alifimoff et al, 1989). We plotted the percentage of inhibition of the 5-HT2A receptor function produced by the alcohols as a function of the carbon chain length using the concentration that produces loss of righting reflex in the tadpoles (fig. 2B). Although short-chain alcohols (ethanol to hexanol) inhibited 5-HT responses at anesthetic concentrations, long-chain alcohols (decanol, undecanol and dodecanol) had little or no effect on the 5-HT response at anesthetic concentrations.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   A, Effects of n-alcohols on current evoked by 10 nM 5-HT in oocytes expressing 5-HT2A receptors. Percentage inhibition of the effects of 5-HT (10 nM) by ethanol (C2, bullet ), propanol (C3, down-triangle), butanol (C4, black-down-triangle ), hexanol (C6, square ), octanol (C8, black-square), decanol (C10, triangle ), undecanol (C11, black-triangle) or dodecanol (C12, diamond ) in oocytes expressing 5-HT2A receptors. Inhibition of the effects of 5-HT (10 nM) was greater when shorter-chain alcohols were tested (ethanol to octanol). Little or no inhibition was found when decanol, undecanol or dodecanol was tested. Each point represents a minimum of five separate experiments. Data are mean ± S.E.M. of 5 to 10 oocytes. B, Comparison of changes in 5-HT receptor function by alcohol concentrations that produce loss of righting reflex in tadpoles. The percentage change of 5-HT receptor function produced by the alcohols ethanol-dodecanol (using EC50 value for producing loss of righting reflex in tadpoles from Alifimoff et al., 1989) was plotted as a function of the carbon chain length. Data are mean ± S.E.M. of 5 to 8 separate oocytes.

Inhibition by halothane, F3, F6 and F8 of currents activated by 5-HT. The effects of the volatile anesthetics halothane and F3 on 5-HT-induced currents are shown in figure 3A. Halothane inhibited the 5-HT-induced currents in a concentration-dependent manner. The 5-HT responses were decreased to 44 ± 7%, 14 ± 5% and 5.5 ± 2.7% of the control by 0.25, 1 and 2 mM halothane, respectively. Similar to halothane, F3 also inhibited the 5-HT responses in a concentration-dependent manner (fig. 3A). We also looked at the effects of the nonanesthetics F6 and F8 on the 5-HT response. Although F8 had no effect on 5-HT-induced currents, F6 produced ~30% inhibition at 1.1 µM (0.06 MAC) (fig. 3A) and similar inhibition at 1 MAC (fig. 3B). Single concentrations of intravenous anesthetics propofol (10 µM), ketamine (100 µM), pentobarbital (100 µM) and etomidate (100 µM) did not affect the 5-HT response (table 1).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 3.   A, Effects of anesthetics (halothane and F3) and nonanesthetics (F6 and F8) on the current evoked by 10 nM 5-HT in oocytes expressing 5-HT2A receptors. Halothane (0.125-2 mM), F3 (0.2-0.8 mM), F6 (1.1-17.8 µM) or F8 (2.2-8.8 µM) was preapplied for 2 min before being coapplied with 5-HT (10 nM) for 20 sec. Data are mean ± S.E.M. of 5 to 8 oocytes. B, Effects of 1 MAC concentrations of halothane, F3, F6 and F8 on currents evoked by 10 nM 5-HT in oocytes expressing 5-HT2A receptors. The MAC concentrations of halothane and F3 are 0.25 and 0.8 mM, respectively. The predicted MAC concentrations of F6 and F8 are 17.8 and 8.8 µM, respectively. Data are mean ± S.E.M. of 5 to 8 oocytes. *, P < .05 vs. control response with 10 nM 5-HT (paired t test).


                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Effects of intravenous anesthetics (propofol, ketamine, etomidate and pentobarbital) on currents evoked by 5-HT2A receptors expressed in X. laevis oocytes.

We compared the effects of halothane, F3, F6 and F8 at 1 MAC (or predicted MAC in the case of F6 and F8) concentrations for the ability to inhibit 5-HT-induced currents (fig. 3B). The anesthetics F3 strongly inhibited the effects of 5-HT on 5-HT2A receptors. At the predicted MAC concentration, the halogenated nonanesthetic compound F6 decreased the 5-HT response to the same extent as halothane. F8 had little effect on the 5-HT2A receptor function.

Ethanol, octanol and anesthetic inhibition of 5-HT2A receptor-mediated current and the role of PKC. Because PKC plays an important role in the regulation of G protein-coupled receptors (Kato et al., 1988; Manzoni et al., 1990; Moran and Dascal, 1988; Sakuta et al., 1991; Sanna et al., 1994; Singer, 1990), we investigated whether the inhibitory effects of ethanol and octanol on 5-HT2A could be modulated by this protein kinase. For this purpose, the effects of ethanol on 5-HT2A receptors were studied with X. laevis oocytes that were pretreated with the PKC inhibitor GF109203X (200 nM) (Toullec et al., 1991) and the nonspecific kinase inhibitor staurosporine (800 nM). As shown in figure 4, GF109203X treatment (200 nM) enhanced 5-HT2A receptor function. After a 20-min incubation of GF109203X, the response of 5-HT increased to 2.5 times the initial current, and this enhancement continued for 3 hr. Sanna et al. (1994) previously reported that 12- to 16-hr incubation of staurosporine (800 nM) blocks the inhibitory effects of ethanol on 5-HT2C. We investigated whether the effects of GF109203X (200 nM) and staurosporine (800 nM) blocked the inhibitory effects of ethanol on 5-HT2A. The inhibition by 200 mM ethanol on 5-HT2A receptor function was blocked in oocytes exposed to these inhibitors (fig. 5A). The inhibitory effects of octanol (0.05 and 0.1 mM) were also abolished by the treatment with GF109203X (table 2), as were the inhibitory effects of halothane and F3. However, GF109203X did not affect F6 modulation of 5-HT2A receptors (fig. 5B).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   GF109203X enhanced 5-HT-induced current in oocytes expressing 5-HT2A receptors. Oocytes were incubated with GF109203X (200 nM) for 0 to 3 hr. 5-HT (10 nM) was applied at 5, 20, 40, 60, 120 and 180 min in oocytes that were treated with GF109203X (bullet ) and at 20, 40, 60, 120 and 180 min in oocytes without treatment with GF109203X as control (down-triangle). Data are mean ± S.E.M. of 10 oocytes.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 5.   A, GF109203X or staurosporine blocked the ethanol inhibition of 5-HT-induced responses. In oocytes expressing 5-HT2A receptors, oocytes were incubated with GF109203X (200 nM) or staurosporine (800 nM) for 12 to 16 hr. Ethanol (200 mM) was preapplied for 2 min before being coapplied with 10 nM 5-HT for 20 sec. Data are mean ± S.E.M. of 5 to 8 oocytes. ***, P < .001, by t test using Dunnett's correction for multiple comparisons. B, GF109203X (GF) blocked the anesthetic (halothane and F3) but not the nonanesthetic (F6) inhibition of 5-HT-induced responses. Oocytes were incubated with 200 nM GF109203X for 12 to 16 hr. Halothane (2 mM), F3 (0.8 mM), F6 (18 µM) or F8 (9 µM) was preapplied for 2 min before being coapplied with 5-HT (10 nM) for 20 sec. The anesthetics and nonanesthetics were preapplied for 2 min before being coapplied with 10 nM 5-HT for 20 sec. Data are mean ± S.E.M. of 5 to 8 separate determinations. **, P < .01, by one-way analysis of variance.


                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
Effects of GF109203X on the inhibition of octanol on currents evoked by 10 nM 5-HT on 5-HT2A receptors expressed in X. laevis oocytes

The effects of ethanol on desensitization 5-HT2A receptor responses. Activation of PKC promotes desensitization of G protein-coupled receptors (Sakuta et al., 1991; Singer et al., 1990; Tan and Marty, 1991). Sanna et al. (1994) showed that ethanol enhances the rate of current desensitization induced by repeated applications of 5-HT on 5-HT2C receptors. We investigated the effects of ethanol on desensitization of 5-HT2A receptors and further examined whether inhibition of PKC activity would reduce desensitization. Desensitization of 5-HT2A receptors was studied using repeated 200 nM 5-HT applications at 3-min intervals (fig. 6). The current amplitude decreased gradually and reached 14.5 ± 0.5% of the maximum response after 21 min (eight applications of 5-HT). Continuous application of ethanol (100 mM) accelerated the desensitization of the 5-HT response. In agreement with previous reports (Sanna et al., 1994), treatment with a PKC inhibitor, GF109203X, decreased desensitization produced by repeated application of 5-HT.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Desensitization of Ca2+-activated Cl- current induced by repeated applications of 5-HT is enhanced by ethanol and inhibited by GF109203X. Current produced by repeated (every 3 min) 20-sec bath applications of 200 nM 5-HT were recorded in oocytes perfused in the absence or in the continued presence of 100 mM ethanol or in oocytes preincubated with 200 nM GF109203X for 12 to 16 hr. Data are percentage of initial response ± S.E.M. produced by 5-HT response of 8 different oocytes. Analysis of variance for repeated measures showed a significant effect of time [F = 58(7,9), P < .0001], treatment [F = 40(2,14), P < .0001] and the interaction between time and treatment [F = 2(14, 38), P < .05].

    Discussion
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Effects of ethanol and kinase inhibitors on 5-HT2A receptors. Our results demonstrate that acute exposure to ethanol inhibits 5-HT2A receptor function. Stimulation of the 5-HT2A receptor leads to the activation of PLC, a process that is mediated by a G protein, resulting in the formation of IP3 and DAG. IP3 promotes, through its interaction with IP3 receptors, the release of Ca2+ from the endoplasmic reticulum, and this in turn triggers the opening of Cl- channels in oocytes (Pritchett et al., 1988). The direct injection of either IP3 or GTPgamma S also induces currents via the Ca2+-activated Cl- channel; however, ethanol has no effect on these currents, suggesting that ethanol does not interfere with IP3-induced Ca2+ release, with the binding of guanine nucleotides to G proteins or with the coupling between G proteins and PLC (Sanna et al., 1994). The PKC inhibitor GF109203X and the nonspecific kinase inhibitor, staurosporine, abolished the ethanol-induced inhibition of 5-HT2A receptor function. Moreover, ethanol increased the desensitization produced by repeated stimulations with 5-HT. The inhibition of ethanol was not reversed by increased 5-HT concentration. These data are similar to those obtained by Sanna et al. (1994) for the 5-HT2C receptor and suggest that the action of ethanol on both subtypes of 5-HT2 receptors involves PKC modulation.

The PKC inhibitor GF109203X markedly enhanced the action of 5-HT on the function of 5-HT2A receptors. This is likely due to inhibition of receptor desensitization. Activation of the receptor produces an activation of PKC (due to production of diacylglycerol and elevation of intracellular calcium after activation of PLC). The increased activity of PKC results in a rapid desensitization of 5-HT receptor function, which attenuates the peak current (Sakuta et al., 1991; Sanna et al., 1994). Thus, blockade of this negative feedback loop would be expected to enhance actions of 5-HT, as observed in our study.

Our results suggest several mechanisms by which ethanol inhibits 5-HT2A receptor function: (1) ethanol may inhibit 5-HT2A function by activating PKC or (2) ethanol may directly inhibit the 5-HT2A receptor and PKC may alter the receptor sensitivity to ethanol indirectly. Recently, another possibility was raised by Mitchell et al. (1996), who reported that a series of alcohols, which include ethanol, modulates the activation of a G protein-coupled receptor (rhodopsin) by a lipid-mediated mechanism. In support of the first hypothesis, several studies suggest that ethanol activates PKC activity in vivo by promoting its translocation from the cytosol to the membrane fraction (DePetrillo and Swift, 1992; Skwish and Shain, 1990; Tuominen et al., 1992). Previously, Sanna et al. (1994) suggested that ethanol inhibits the 5-HT2C receptor by enhancing PKC-dependent desensitization, perhaps due to phosphorylation of the 5-HT2C receptor. Moreover, 5-HT2A receptors have 11 serine/threonine residues, which may be possible targets for phosphorylation by this protein kinase (Bach et al., 1993; Boess and Martin, 1994). Mutation of these amino acids is required to test hypothesis that receptor phosphorylation is responsible for actions of ethanol.

The acute inhibition of 5-HT2A and 5-HT2C receptor function by ethanol may be related to the effects of chronic alcohol treatments on these receptors. For example, chronic consumption of ethanol changes the density and function of 5-HT2C receptors in choroid plexus of rats (Pandey et al., 1993; Pandey and Pandey, 1996). Thus, it is possible that the initial inhibition of 5-HT receptor function leads to a compensatory upregulation of receptor density with chronic exposure. This could contribute to ethanol tolerance and dependence, as discussed by others (Pandey et al., 1993; Pandey and Pandey, 1996).

Effects of long-chain alcohols on 5-HT2A receptors. The effects of alcohol on receptor-gated ion channels display a clear dependence on chain length. Recently, several investigators reported that the effects of long-chain alcohols distinguish between several classes of receptor-gated ion channels. For example, long-chain alcohols (e.g., decanol and dodecanol) enhance both GABAA receptor function (Dildy-Mayfield et al., 1996a; Kurata et al., 1993; Nakahiro et al., 1991) and glycine receptor activity (Mascia et al., 1996) while having no effect on NMDA, AMPA or kainate (Dildy-Mayfield et al., 1996a; Peoples and Weight, 1995) or ATP (Li et al., 1994) receptor function. This lack of effect of long-chain alcohols has been termed "cutoff." Unlike these receptor-gated ion channels, the effects of alcohol chain length on G protein-coupled receptors have not been studied. Our results demonstrate that the 5-HT2A receptor exhibits a cutoff like that seen with NMDA, AMPA and kainate receptors (Dildy-Mayfield et al., 1996a; Peoples and Weight, 1995).

Regarding the cutoff for n-alcohols on GABA receptors, it is interesting to note that most recombinant GABA receptors are sensitive to decanol and dodecanol (Dildy-Mayfield et al., 1996a), but receptors formed by rho subunits are not. These rho, or GABAc, receptors are inhibited by alcohols with a cutoff similar to that found for the 5-HT2A receptor (Mihic and Harris, 1996), and these receptors are also inhibited by PKC activators (Kusama et al., 1995). Thus, there may be a common mechanism of action for alcohols on some metabotropic and ionotropic receptors.

As discussed by Franks and Lieb (1985), the concept of the cutoff for these receptor-gated ion channels implies that a small hydrophobic pocket allows short-chain alcohols to bind to the protein and modulate receptor function, whereas long-chain alcohols would be unable to fit and therefore unable to alter receptor function. In our results, the inhibitory effect of octanol on the 5-HT2A receptor was blocked in the oocytes that were treated by GF109203X. These results suggest that octanol may inhibit the 5-HT2A receptor by modulating PKC activity. These results raise the possibility that PKC is a target for n-alcohol action and the PKC may play an important role in the cutoff for the 5-HT2A receptor.

Inhibition by anesthetics of 5-HT2A receptor function. Both halothane and F3 inhibit currents induced via 5-HT2A receptors at a 1 MAC concentration. Pretreatment with the protein kinase inhibitor GF109203X abolished the inhibitory effects of these anesthetics. These results suggest that these anesthetics inhibit the 5-HT-induced current by a PKC-sensitive pathway similar to the one found with ethanol and octanol.

It is interesting that the nonanesthetic F6 has inhibitory effects and the protein kinase inhibitor did not abolish the inhibitory effects of F6. These results suggest that the inhibitory mechanism dose not involve PKC and is different from that of ethanol, F3 and halothane. It has been reported that F6 and F8 have little effect on receptor-gated ion channels. For example, Dildy-Mayfield et al. (1996B) showed that F6 and F8 have no effects on AMPA or kainate responses, and Mihic et al. (1994) showed that F6 and F8 do not affect the GABAA receptor. Recently, Kandel et al. (1996) reported that a low concentration of F6 abolishes learning and memory. It is interesting to note that the 5-HT2 receptors are closely related to muscarinic receptors (Peralta et al., 1988), which are critical for numerous central processes, including memory and learning (Wess, 1993). Moreover, we found inhibitory effects of F6 on the m1 receptor expressed in oocytes.2 Thus, novel halogenated nonanesthetics, such as F6, may have inhibitory effects on G protein-coupled receptors, influencing central processes such as memory and learning.

Previous studies of anesthetics on PKC activity have yielded contradictory results. In vitro studies demonstrate that halothane has inhibitory effects on brain PKC (Hemmings et al., 1995; Hemmings and Adamo, 1994; Slater et al., 1993), but halothane was reported to stimulate PKC activity in both brain cytosol (Tsuchiya et al., 1988) and PC12 cells (Tas and Koschel, 1991). Park et al. (1996) reported different effects of halothane and isoflurane on PKC activity in vivo: halothane inhibited PKC-induced contraction in rat coronary arteries, and isoflurane enhanced it. In our studies, the PKC inhibitor GF109203X blocked the inhibitory action of ethanol, halothane and F3 on 5-HT2A receptors. Although the effects of anesthetics on PKC activity are controversial, our results suggest that the inhibitory effects of halothane and F3 require PKC.

Intravenous anesthetics did not affect 5-HT2A receptor function. However, several investigators have reported the effects of intravenous anesthetics on PKC activity. Pentobarbital has inhibitory effects on PKC activity in synaptosomes (Ki = 480 µM) (Deshmukh et al., 1989), and the activity of purified rat brain PKC was inhibited to ~50% by 1 mM of pentobarbital (Mikawa et al., 1990). Hemmings and Adamo (1994) reported that propofol activate purified brain PKC activity (EC50 = 240 µM). There have been no reports demonstrating the effects of ketamine and etomidate on PKC activity. However, the concentrations of anesthetics required to affect the PKC activity in these studies were much higher (~2-10-fold) than the concentration used in our study. The EC50 values of pentobarbital, ketamine, propofol (Franks and Lieb., 1994; Harris et al., 1995; Lin et al., 1992) and etomidate (Fragen, 1994) for producing anesthesia in mammals are 25, 182, 8 and 0.4 µM, respectively. Thus, clinically relevant concentrations of these anesthetics have little or no effect on PKC activity and no effect on the 5-HT2A receptor.

These results demonstrate that volatile anesthetics and n-alcohols up to octanol inhibit the function of 5-HT2A receptors expressed in X. laevis oocytes. This action requires PKC activity and is most easily explained by activation of PKC by these agents leading to enhanced desensitization of the 5-HT receptor response, but available data do not rule out other possibilities. A related issue is the site of action of these anesthetics. As discussed above, it is likely to be PKC or the 5-HT receptor rather than downstream signaling machinery because ethanol does not alter the release of intracellular calcium produced by stimuli subsequent to receptor activation (e.g., GTPgamma S or IP3) (Sanna et al., 1994) and halothane does not alter the action of angiotensin II receptors even though they share the same signaling steps as other metabotropic receptors (Durieux, 1996). It is possible that anesthetics alter the phosphorylation of the 5-HT2A receptor and thereby inhibit its function, and future studies should directly address this hypothesis with the use of site-directed mutagenesis or measurement of receptor phosphorylation.

Our results also address the role of 5-HT2A receptors in anesthesia. Although volatile anesthetics inhibited these receptors at concentrations equivalent to MAC in vivo, the amount of inhibition varied markedly among the agents tested in this study. For example, halothane had a small effect, ethanol and F3 had large effects but decanol and dodecanol had no effect. The injectable anesthetics were also without effect. In addition, the nonanesthetic F6 produced effects that were as pronounced as those of halothane. From these data, we conclude that the 5-HT2A receptor is not likely to be important for the immobility component of anesthesia. However, this receptor may be important in other actions of some of these drugs. For example, ethanol inhibits this receptor at subanesthetic concentrations, and this action may be important for other aspects of intoxication. Likewise, F6 disrupts learning and memory, and this may be related to its action on metabotropic receptors. It will be of interest to determine whether other metabotropic receptors show similar sensitivity to F6 and a similar cutoff for the n-alcohols.

    Acknowledgments

We thank Drs. M. P. Mascia, S. J. Mihic, M. Wick, C. F. Valenzuela and T. Vanderah for kind discussion and technical suggestions.

    Footnotes

Accepted for publication February 14, 1997.

Received for publication November 20, 1996.

1   Supported by the Department of Veterans Affairs, NIH Grants GM 47818 and AA 06399, the Yokoyama Clinical Pharmacology Foundation and the Uehara Memorial Foundation.

2   K. Minami, M. Minami and R. A. Harris, unpublished observations.

Send reprint requests to: Dr. R. Adron Harris, Department of Pharmacology, University of Colorado Health Sciences Center and Veterans Affairs Medical Center, 4200 E. 9th Ave., Box C236, Denver, Colorado, 80262. E-mail: adron.harris{at}uchsc.edu

    Abbreviations

AMPA, alpha -amino 3-hydroxy-5-methyl-4-isoxozolepropionic acid; DAG, diacylglycerol; DMSO, dimethylsulfoxide; F3, 1-chloro-1,2,2-trifluorocyclobutane; F6, 1,2-dichlorohexafluorocyclobutane; F8, 2,3-chloro-octafluorobutane; GABA, gamma -aminobutyric acid; GF, GF109203X; GTPgamma S, guanosine-5'-O-(3-thio)triphosphate; HEPES, 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid; 5-HT, 5-hydroxytryptamine; IP3, myo-inositol-1,4,5-triphosphate; MAC, minimum alveolar concentration; MBS, modified Barth's solution; NMDA, N-methyl-D-aspartate; PLC, phospholipase C.

    References
Top
Abstract
Introduction
Procedures
Results
Discussion
References


0022-3565/97/2813-1136$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
E. I. Eger II, D. E. Raines, S. L. Shafer, H. C. Hemmings Jr, and J. M. Sonner
Is a New Paradigm Needed to Explain How Inhaled Anesthetics Produce Immobility?
Anesth. Analg., September 1, 2008; 107(3): 832 - 848.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. Hara, T. Yamakura, T. Sata, and R. A. Harris
The Effects of Anesthetics and Ethanol on {alpha}2 Adrenoceptor Subtypes Expressed with G Protein-Coupled Inwardly Rectifying Potassium Channels in Xenopus Oocytes
Anesth. Analg., November 1, 2005; 101(5): 1381 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Nakamura, K. Minami, Y. Uezono, T. Horishita, J. Ogata, M. Shiraishi, T. Okamoto, T. Terada, and T. Sata
The Effects of the Tramadol Metabolite O-Desmethyl Tramadol on Muscarinic Receptor-Induced Responses in Xenopus Oocytes Expressing Cloned M1 or M3 Receptors
Anesth. Analg., July 1, 2005; 101(1): 180 - 186.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Shiga, K. Minami, K. Segawa, Y. Uezono, M. Shiraishi, T. Sata, C. Yamamoto, and K. Sung-Teh
The Inhibition of Aortic Smooth Muscle Cell Proliferation by the Intravenous Anesthetic Ketamine
Anesth. Analg., November 1, 2004; 99(5): 1408 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Ogata, K. Minami, Y. Uezono, T. Okamoto, M. Shiraishi, A. Shigematsu, and Y. Ueta
The Inhibitory Effects of Tramadol on 5-Hydroxytryptamine Type 2C Receptors Expressed in Xenopus Oocytes
Anesth. Analg., May 1, 2004; 98(5): 1401 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. M. Sonner, J. F. Antognini, R. C. Dutton, P. Flood, A. T. Gray, R. A. Harris, G. E. Homanics, J. Kendig, B. Orser, D. E. Raines, et al.
Inhaled Anesthetics and Immobility: Mechanisms, Mysteries, and Minimum Alveolar Anesthetic Concentration
Anesth. Analg., September 1, 2003; 97(3): 718 - 740.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Zhang, M. J. Laster, E. I Eger II, C. R. Stabernack, and J. M. Sonner
Blockade of 5-HT2A Receptors May Mediate or Modulate Part of the Immobility Produced by Inhaled Anesthetics
Anesth. Analg., August 1, 2003; 97(2): 475 - 479.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Okamoto, K. Minami, Y. Uezono, J. Ogata, M. Shiraishi, A. Shigematsu, and Y. Ueta
The Inhibitory Effects of Ketamine and Pentobarbital on Substance P Receptors Expressed in Xenopus Oocytes
Anesth. Analg., July 1, 2003; 97(1): 104 - 110.
[Abstract]